vs

Side-by-side financial comparison of CF BANKSHARES INC. (CFBK) and NeuroPace Inc (NPCE). Click either name above to swap in a different company.

NeuroPace Inc is the larger business by last-quarter revenue ($26.6M vs $15.7M, roughly 1.7× CF BANKSHARES INC.). CF BANKSHARES INC. runs the higher net margin — 40.0% vs -10.3%, a 50.3% gap on every dollar of revenue. On growth, NeuroPace Inc posted the faster year-over-year revenue change (23.9% vs 12.6%). CF BANKSHARES INC. produced more free cash flow last quarter ($18.2M vs $409.0K). Over the past eight quarters, NeuroPace Inc's revenue compounded faster (21.1% CAGR vs 13.7%).

CF Bankshares Inc. is a U.S.-based regional bank holding company operating through its community bank subsidiary. It offers a full suite of personal and commercial banking solutions including deposit products, various loan options, wealth management services and digital banking tools, primarily serving individual consumers and small-to-medium business clients across the U.S. Midwest region.

NeuroPace Inc is a medical technology company focused on developing and commercializing innovative implantable neurostimulation systems to treat neurological disorders, primarily drug-resistant epilepsy. Its core RNS System delivers personalized responsive stimulation to reduce seizure frequency, serving patients across North America and select global markets via partnerships with healthcare providers.

CFBK vs NPCE — Head-to-Head

Bigger by revenue
NPCE
NPCE
1.7× larger
NPCE
$26.6M
$15.7M
CFBK
Growing faster (revenue YoY)
NPCE
NPCE
+11.2% gap
NPCE
23.9%
12.6%
CFBK
Higher net margin
CFBK
CFBK
50.3% more per $
CFBK
40.0%
-10.3%
NPCE
More free cash flow
CFBK
CFBK
$17.8M more FCF
CFBK
$18.2M
$409.0K
NPCE
Faster 2-yr revenue CAGR
NPCE
NPCE
Annualised
NPCE
21.1%
13.7%
CFBK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CFBK
CFBK
NPCE
NPCE
Revenue
$15.7M
$26.6M
Net Profit
$5.7M
$-2.7M
Gross Margin
77.4%
Operating Margin
43.4%
-6.6%
Net Margin
40.0%
-10.3%
Revenue YoY
12.6%
23.9%
Net Profit YoY
29.9%
48.0%
EPS (diluted)
$0.88
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CFBK
CFBK
NPCE
NPCE
Q4 25
$15.7M
$26.6M
Q3 25
$15.5M
$27.4M
Q2 25
$15.6M
$23.5M
Q1 25
$14.1M
$22.5M
Q4 24
$14.0M
$21.5M
Q3 24
$13.1M
$21.1M
Q2 24
$12.6M
$19.3M
Q1 24
$12.2M
$18.1M
Net Profit
CFBK
CFBK
NPCE
NPCE
Q4 25
$5.7M
$-2.7M
Q3 25
$2.3M
$-3.5M
Q2 25
$5.0M
$-8.7M
Q1 25
$4.4M
$-6.6M
Q4 24
$4.4M
$-5.3M
Q3 24
$4.2M
$-5.5M
Q2 24
$1.7M
$-7.5M
Q1 24
$3.1M
$-8.9M
Gross Margin
CFBK
CFBK
NPCE
NPCE
Q4 25
77.4%
Q3 25
77.4%
Q2 25
77.1%
Q1 25
77.0%
Q4 24
75.4%
Q3 24
73.2%
Q2 24
73.4%
Q1 24
73.6%
Operating Margin
CFBK
CFBK
NPCE
NPCE
Q4 25
43.4%
-6.6%
Q3 25
17.5%
-9.5%
Q2 25
41.1%
-29.0%
Q1 25
39.5%
-22.9%
Q4 24
36.9%
-17.0%
Q3 24
40.4%
-20.1%
Q2 24
15.4%
-32.4%
Q1 24
30.9%
-41.6%
Net Margin
CFBK
CFBK
NPCE
NPCE
Q4 25
40.0%
-10.3%
Q3 25
15.1%
-12.8%
Q2 25
32.3%
-36.8%
Q1 25
31.4%
-29.3%
Q4 24
35.2%
-24.5%
Q3 24
32.2%
-25.9%
Q2 24
13.5%
-39.0%
Q1 24
25.2%
-49.2%
EPS (diluted)
CFBK
CFBK
NPCE
NPCE
Q4 25
$0.88
$-0.08
Q3 25
$0.36
$-0.11
Q2 25
$0.77
$-0.26
Q1 25
$0.68
$-0.21
Q4 24
$0.68
$-0.16
Q3 24
$0.65
$-0.19
Q2 24
$0.26
$-0.26
Q1 24
$0.47
$-0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CFBK
CFBK
NPCE
NPCE
Cash + ST InvestmentsLiquidity on hand
$259.0M
$61.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$184.4M
$19.0M
Total Assets
$2.1B
$105.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CFBK
CFBK
NPCE
NPCE
Q4 25
$259.0M
$61.1M
Q3 25
$272.4M
$60.0M
Q2 25
$275.7M
$62.1M
Q1 25
$241.0M
$66.3M
Q4 24
$235.3M
$52.8M
Q3 24
$233.5M
$56.8M
Q2 24
$241.8M
$55.5M
Q1 24
$236.9M
$58.9M
Stockholders' Equity
CFBK
CFBK
NPCE
NPCE
Q4 25
$184.4M
$19.0M
Q3 25
$179.3M
$18.5M
Q2 25
$177.0M
$19.4M
Q1 25
$172.7M
$24.3M
Q4 24
$168.4M
$8.0M
Q3 24
$164.0M
$9.8M
Q2 24
$159.6M
$9.9M
Q1 24
$158.0M
$14.3M
Total Assets
CFBK
CFBK
NPCE
NPCE
Q4 25
$2.1B
$105.6M
Q3 25
$2.1B
$107.3M
Q2 25
$2.1B
$106.1M
Q1 25
$2.1B
$110.2M
Q4 24
$2.1B
$94.6M
Q3 24
$2.1B
$96.3M
Q2 24
$2.0B
$94.4M
Q1 24
$2.0B
$98.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CFBK
CFBK
NPCE
NPCE
Operating Cash FlowLast quarter
$18.7M
$506.0K
Free Cash FlowOCF − Capex
$18.2M
$409.0K
FCF MarginFCF / Revenue
115.6%
1.5%
Capex IntensityCapex / Revenue
3.1%
0.4%
Cash ConversionOCF / Net Profit
3.26×
TTM Free Cash FlowTrailing 4 quarters
$33.4M
$-11.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CFBK
CFBK
NPCE
NPCE
Q4 25
$18.7M
$506.0K
Q3 25
$5.5M
$-1.9M
Q2 25
$8.0M
$-2.1M
Q1 25
$2.2M
$-7.5M
Q4 24
$14.2M
$-4.8M
Q3 24
$-1.3M
$-1.7M
Q2 24
$4.0M
$-3.9M
Q1 24
$-1.2M
$-7.5M
Free Cash Flow
CFBK
CFBK
NPCE
NPCE
Q4 25
$18.2M
$409.0K
Q3 25
$5.2M
$-2.0M
Q2 25
$7.8M
$-2.3M
Q1 25
$2.2M
$-7.5M
Q4 24
$13.9M
$-4.8M
Q3 24
$-1.3M
$-1.8M
Q2 24
$4.0M
$-4.0M
Q1 24
$-1.2M
$-7.6M
FCF Margin
CFBK
CFBK
NPCE
NPCE
Q4 25
115.6%
1.5%
Q3 25
33.6%
-7.2%
Q2 25
50.3%
-9.6%
Q1 25
15.2%
-33.4%
Q4 24
99.6%
-22.5%
Q3 24
-9.9%
-8.7%
Q2 24
31.6%
-20.6%
Q1 24
-9.5%
-42.1%
Capex Intensity
CFBK
CFBK
NPCE
NPCE
Q4 25
3.1%
0.4%
Q3 25
1.7%
0.1%
Q2 25
0.7%
0.7%
Q1 25
0.4%
0.2%
Q4 24
1.9%
0.2%
Q3 24
0.2%
0.5%
Q2 24
0.1%
0.3%
Q1 24
0.0%
0.6%
Cash Conversion
CFBK
CFBK
NPCE
NPCE
Q4 25
3.26×
Q3 25
2.34×
Q2 25
1.58×
Q1 25
0.50×
Q4 24
3.21×
Q3 24
-0.30×
Q2 24
2.35×
Q1 24
-0.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons